Mayo-Rochester

Rochester, Minnesota 55905

5 studies enrolling now · 10 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Leiomyosarcoma, Advanced Pheochromocytoma and Paraganglioma, Advanced Soft-tissue Sarcoma, Anemia, Breast Cancer, C Difficile Colitis, Cervical Cancer, Chronic Myelomonocytic Leukemia, Clostridium Difficile, Clostridium Difficile Infection, Endometrial Cancer

Studies at this site

• Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma — Recruiting now
• An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) — Recruiting now
• A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations — Recruiting now
• A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) — Enrolling by invitation
• Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin — Running, not enrolling
• Lurbinectedin + Doxorubicin In Leiomyosarcoma — Running, not enrolling
• Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel — Available (expanded access)
• Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients — Completed
• FQ Restriction for the Prevention of CDI — Completed
• A Trial of TH-302 in Combination With Doxorubicin Versus Doxorubicin Alone to Treat Patients With Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma — Completed